• If you are wondering whether Colgate-Palmolive is fairly priced at around US$93 a share, you are not alone. Many investors are asking the same question about what they are really paying for here.
• The stock has seen mixed returns, with a 4.4% decline over the last 7 days and a 1.5% decline over the last 30 days, while still showing a 19.7% gain year to date and a 39.6% return over 3 years.
• Recent news flow around Colgate-Palmolive has focused on its position as a global consumer staples brand and how that fits into portfolios that seek consistency through different market conditions. This context helps explain why investors might reassess the balance between defensiveness, growth expectations, and the price they are willing to pay for the shares.
• Our valuation checks give Colgate-Palmolive a 2 out of 6 valuation score, suggesting that some measures point to potential undervaluation while others do not. Next, we will look at these traditional valuation approaches before finishing with a broader way to think about what the stock might be worth.

Colgate-Palmolive scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Colgate-Palmolive Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a company could be worth by projecting its future cash flows and discounting them back to today in dollar terms. For Colgate-Palmolive, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections rather than earnings multiples.

The latest twelve month Free Cash Flow is about $3.58b. Analyst estimates and subsequent extrapolations suggest projected Free Cash Flow of $4.10b by 2030, with intermediate years such as 2026 and 2027 modeled at $3.29b and $3.48b respectively. Simply Wall St uses analyst inputs for the nearer years and then extrapolates out to 2035 to build a full 10 year cash flow path.

Discounting those projected cash flows back to today produces an estimated intrinsic value of about $125.40 per share. Against a current share price around $93, this DCF output implies the stock trades at a 25.8% discount to that estimate, suggesting the shares appear undervalued on this cash flow view alone.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Colgate-Palmolive is undervalued by 25.8%. Track this in your watchlist or portfolio, or discover 47 more high quality undervalued stocks.

Approach 2: Colgate-Palmolive Price vs Earnings

P/E is a useful yardstick for a profitable company like Colgate-Palmolive because it ties what you pay directly to the earnings the business is already generating. Investors usually accept a higher or lower P/E depending on what they expect for future earnings growth and how risky they think those earnings might be.

Colgate-Palmolive currently trades on a P/E of 34.96x. That sits above the Household Products industry average of 16.94x and also above the broader peer group average of 23.60x. On those simple comparisons, you are paying a higher price for each dollar of earnings than you would for many peers in the sector.

Simply Wall St’s Fair Ratio for Colgate-Palmolive is 28.10x. This is a proprietary P/E level that reflects factors such as the company’s earnings growth profile, its industry, profit margins, market capitalization and key risks. Because it blends these drivers rather than just lining the stock up against a crude industry or peer average, it aims to be a more tailored benchmark for what might be a reasonable multiple.

Comparing the Fair Ratio of 28.10x with the current P/E of 34.96x suggests the shares are pricing in a richer earnings multiple than this framework implies.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Colgate-Palmolive Narrative

Earlier we mentioned that there is an even better way to think about valuation, so let us introduce you to Narratives. These are simply your story about Colgate-Palmolive linked to your own numbers such as expected revenue, earnings, margins and a fair value estimate, all brought together in a single view on Simply Wall St’s Community page. This view compares your Fair Value to the current price, updates automatically when new news or earnings arrive, and can look very different from other investors’ views. For example, one person might see Colgate-Palmolive as worth closer to US$106 based on confidence in its 2030 plan and emerging markets, while another might anchor nearer US$83 because they focus more on cost pressures and category risks.

Do you think there's more to the story for Colgate-Palmolive? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.